Methadone: A Flicker Of Light In The Dark
Methadone: A Flicker Of Light In The Dark
Methadone: A Flicker Of Light In The Dark
Would you like to react to this message? Create an account in a few clicks or log in to continue.

Methadone: A Flicker Of Light In The Dark

To provide a better understanding of the very important role methadone plays in the treatment of addiction.
 
HomeHome  PortalPortal  GalleryGallery  Latest imagesLatest images  RegisterRegister  Log inLog in  

 

 Now this is interesting.. A New Drug For Opioid Withdrawal?

Go down 
2 posters
AuthorMessage
D
Admin
D


Female
Number of posts : 484
Age : 65
Location : Vermont
Registration date : 2009-03-05

Now this is interesting.. A New Drug For Opioid Withdrawal? Empty
PostSubject: Now this is interesting.. A New Drug For Opioid Withdrawal?   Now this is interesting.. A New Drug For Opioid Withdrawal? EmptyWed Jun 30, 2010 11:17 pm

Now this is interesting.. A New Drug For Opioid Withdrawal? Light_10



Trial Examines 5-HT3 Antagonist for Opioid Withdrawal

A small, double-blind study has found that the anti-emetic ondansetron can reduce withdrawal symptoms in chronic pain patients weaning off opioid therapy.


The results, presented at the 2010 annual scientific meeting of the American Pain Society, suggest that ondansetron, a 5-HT3 receptor antagonist, may become a useful addition to the armamentarium of opioid withdrawal medications, according to investigators (abstract 310).

Indeed, any tool that helps decrease the distress associated with opioid withdrawal increases the likelihood of a successful detoxification, said Ashok Mallya, MD, medical director of the Opiate Addiction Treatment Program at the VA Medical Center, in St. Louis.

“Current detoxification regimens are inadequate and do not address all of the symptoms of opioid withdrawal. Many patients consequently continue the use just to avoid withdrawal-related distress,” Dr. Mallya told Anesthesiology News. “These impressive preliminary findings suggest [that] ondansetron is an effective non-narcotic agent that may be used as an alternative to the traditional opiate-tapering drugs such as methadone, buprenorphine or naloxone, which require special training or a special setting.”

According to primary investigator Sean Mackey, MD, PhD, chief of pain management, and associate professor at Stanford University School of Medicine, in Stanford, Calif., studies in mice have shown that 5-HT3 receptors are triggered by opioid withdrawal (Hum Psychopharmacol Clin 2008;28:189-194).

To examine whether ondansetron also can help relieve opioid withdrawal symptoms, Dr. Mackey and his team enrolled nine chronic pain inpatients at Stanford’s Comprehensive Pain Interdisciplinary Pain Program.
Subjects had a diverse set of diagnoses and used a variety of opioids, including methadone, oxycodone and hydrocodone. Morphine-equivalent daily doses at the time of admission ranged from 0 to 1.178 g, and between 0 and 40 mg on the day of opioid withdrawal. The study included three women and six men (average age, 44 years).

All participants were weaned off their opioid medications during a one- to two-week period and were concurrently administered a combination of methadone, clonidine, baclofen and cherry syrup during this weaning period. In addition, in a double-blind fashion, patients were given a placebo immediately after a baseline assessment and then 8 mg of ondansetron one hour later. Following each administration, patient pain and withdrawal symptoms were assessed using the 60-point Subjective Opioid Withdrawal Scale (SOWS), the 13-point Objective Opioid Withdrawal Scale (OOWS) and the visual analog scale (VAS).

Dr. Mackey and his team found that OOWS scores dropped from a mean of 4.1 at baseline to 3.2 after placebo and then decreased further to 2.5 after ondansetron administration (placebo vs. baseline, P<0.05; ondansetron vs. baseline, P<0.001; ondansetron vs. placebo, P=NS). Similarly, mean scores on the SOWS fell from 26.3 at baseline to 20.7 after placebo administration and 16.4 after subjects received ondansetron (baseline compared with both placebo and ondansetron, P<0.001). VAS scores dropped from 6.65 at baseline to 6.27 post-placebo and 5.50 one hour after administration of ondansetron (P=NS).

In the presentation of his group’s findings, Dr. Mackey admitted that the effects of ondansetron on withdrawal symptoms may have been masked by the concurrent administration of a pain cocktail that included clonidine, methadone and diclofenac. Furthermore, he noted that the small study population represented a subset of patients with mild withdrawal symptoms that do not represent the severity of withdrawal symptoms exhibited by many opioid-dependent chronic pain patients.

“Our preliminary results suggest patients undergoing withdrawal subjectively improve once they receive ondansetron,” Dr. Mackey said. “However, further studies are needed to explore the relationship between ondansetron and opioid withdrawal symptoms and to identify responders and nonresponders.”

Article Source:
Anesthesiology News
Back to top Go down
http://www.medicalassistedtreatment.org
lilgirllost
Admin
lilgirllost


Female
Number of posts : 863
Age : 51
Location : live in Louisiana but attend MMT clinic in Tx
Job/hobbies : COUPONING & GEOCACHING are my favorite past times but I also love reading and spending time with my husband and kids
Humor : I don't have a sense of humor.............
Registration date : 2009-05-25

Now this is interesting.. A New Drug For Opioid Withdrawal? Empty
PostSubject: Re: Now this is interesting.. A New Drug For Opioid Withdrawal?   Now this is interesting.. A New Drug For Opioid Withdrawal? EmptyTue Jul 06, 2010 6:44 pm

Interesting. Notice that they were giving them methadone as well so wonder which medication was actually doing the "work" or reducing w/drawals? We know that methadone by itself does just fine. They also didn't say what type of doses of methadone they were on which would go a long way in helping to determine this as well. For example, if the pt was getting 120mg of methadone in addition to the clonidine, baclofen and cherry syrup then I don't see how you can say for sure it wasn't the methadone just doing it's job. However, if the methadone dose was only 5 or 10 mg, then we know that isn't going to do much for the opiate tolerant person because they would still having w/drawals so THEN you might could tell if the ondansetron might be making a difference.
Back to top Go down
 
Now this is interesting.. A New Drug For Opioid Withdrawal?
Back to top 
Page 1 of 1
 Similar topics
-
» The mental side of withdrawal
» Interesting New/Blogger from the Ukraine
» Olympia WA, treatment clinic for opioid dependence to increase patients
» IBOGAINE for opiate addiction??? WHAT DO YOU THINK?
» Opioid Abuse Targeted by the FDA

Permissions in this forum:You cannot reply to topics in this forum
Methadone: A Flicker Of Light In The Dark :: News Articles-
Jump to: